BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2990701)

  • 1. Clinical spectrum of HTLV-III in humans.
    Groopman JE
    Cancer Res; 1985 Sep; 45(9 Suppl):4649s-4651s. PubMed ID: 2990701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
    Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
    Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
    [No Abstract]   [Full Text] [Related]  

  • 3. Human T-cell lymphotropic virus type III associated disorders. The spectrum in the heterosexual population.
    Gill PS; Levine AM; Meyer PR; Aguilar SL; Rarick M; Parker JW; Rasheed S
    Arch Intern Med; 1986 Aug; 146(8):1501-4. PubMed ID: 3015064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A classification of HTLV-III infection based on 75 cases seen in a suburban community.
    Kaplan MH; Pahwa SG; Popovic M; Sarngadharan MG; Gallo RC
    Cancer Res; 1985 Sep; 45(9 Suppl):4655s-4658s. PubMed ID: 2990703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of human lymphotrophic retroviruses: an overview.
    Blattner WA; Biggar RJ; Weiss SH; Clark JW; Goedert JJ
    Cancer Res; 1985 Sep; 45(9 Suppl):4598s-4601s. PubMed ID: 2990691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
    Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
    J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and immunological findings in HTLV-III infection.
    Krohn KJ; Antonen J; Valle SL; Kazakevicius R; Saxinger C; Gallo RC; Ranki A
    Cancer Res; 1985 Sep; 45(9 Suppl):4612s-4615s. PubMed ID: 2990694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the isolation of HTLV-III from patients with AIDS and AIDS-related complex and from donors at risk.
    Markham PD; Salahuddin SZ; Popovic M; Patel A; Veren K; Fladager A; Orndorff S; Gallo RC
    Cancer Res; 1985 Sep; 45(9 Suppl):4588s-4591s. PubMed ID: 2990690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological trends of AIDS in the United States.
    Curran JW; Morgan WM; Starcher ET; Hardy AM; Jaffe HW
    Cancer Res; 1985 Sep; 45(9 Suppl):4602s-4604s. PubMed ID: 2990692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiological evidence for HTLV-III infection as the primary etiologic factor for acquired immunodeficiency syndrome.
    Sarngadharan MG; Schüpbach J; Bruch L; Devico A; Markham PD; Wong-Staal F; Gallo RC
    Prog Clin Biol Res; 1985; 182():309-27. PubMed ID: 2994105
    [No Abstract]   [Full Text] [Related]  

  • 11. Transfusion-associated human T-lymphotropic virus type III/lymphadenopathy-associated virus infection from a seronegative donor--Colorado.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Jun; 35(24):389-91. PubMed ID: 3012311
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical spectrum of human retroviral-induced diseases.
    Urba WJ; Longo DL
    Cancer Res; 1985 Sep; 45(9 Suppl):4637s-4643s. PubMed ID: 2990699
    [No Abstract]   [Full Text] [Related]  

  • 13. HTLV-III AIDS link.
    Bennett JA
    Am J Nurs; 1985 Oct; 85(10):1086-9. PubMed ID: 2996353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human T-cell leukemia/lymphotropic retroviruses (HTLV) family: past, present, and future.
    Gallo RC
    Cancer Res; 1985 Sep; 45(9 Suppl):4524s-4533s. PubMed ID: 2990681
    [No Abstract]   [Full Text] [Related]  

  • 15. Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS.
    Tedder RS; Shanson DC; Jeffries DJ; Cheingsong-Popov R; Clapham P; Dalgleish A; Nagy K; Weiss RA
    Lancet; 1984 Jul; 2(8395):125-8. PubMed ID: 6146034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired immune deficiency syndrome (AIDS). Report of the NHMRC Working Party.
    Med J Aust; 1984 Oct; 141(9):561-8. PubMed ID: 6092880
    [No Abstract]   [Full Text] [Related]  

  • 17. Structural and epidemiological features of primate lymphotropic retroviruses.
    Hunsmann G; Schneider J; Bayer H; Jurkiewicz E; Yamamoto N
    Princess Takamatsu Symp; 1984; 15():109-18. PubMed ID: 6100632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Centers for Disease Control, U.S. Department of Health and Human Services.
    Ann Intern Med; 1986 Aug; 105(2):234-7. PubMed ID: 3014942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
    Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inapparent carriers of simian acquired immune deficiency syndrome type D retrovirus and disease transmission with saliva.
    Lerche NW; Osborn KG; Marx PA; Prahalada S; Maul DH; Lowenstine LJ; Munn RJ; Bryant ML; Henrickson RV; Arthur LO
    J Natl Cancer Inst; 1986 Aug; 77(2):489-96. PubMed ID: 3461210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.